Who
Wenbin Jiang
President and CEO
Company insider
Files Form 4 as: President and CEO, Cytek Biosciences.
In numbers
- Trades disclosed
- 224
- Buys
- 0
- Sells
- 22
- Bought
- $0
- Sold
- $4.7M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 22 Jul 2021
- Last trade
- 18 Aug 2026
- Last filed
- 20 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 18 Aug 2026filed 20 Aug 2026 | CTKB Cytek BiosciencesLife-science tools | SEC FORM 4 Code M | —11,781 | filing |
| 18 Aug 2026filed 20 Aug 2026 | CTKB Cytek Biosciencesoption or derivative · Life-science tools | SEC FORM 4 Code M | —22,100 at $0.00 | filing |
| 18 Aug 2026filed 20 Aug 2026 | CTKB Cytek Biosciencesoption or derivative · Life-science tools | SEC FORM 4 Code M | —29,002 at $0.00 | filing |
| 18 Aug 2026filed 20 Aug 2026 | CTKB Cytek Biosciencesoption or derivative · Life-science tools | SEC FORM 4 Code M | —57,212 at $0.00 | filing |
| 18 Aug 2026filed 20 Aug 2026 | CTKB Cytek BiosciencesLife-science tools | SEC FORM 4 Code F | $13K2,869 at $4.67 | filing |
| 18 Aug 2026filed 20 Aug 2026 | CTKB Cytek BiosciencesLife-science tools | SEC FORM 4 Code M | —22,100 | filing |
| 18 Aug 2026filed 20 Aug 2026 | CTKB Cytek Biosciencesoption or derivative · Life-science tools | SEC FORM 4 Code M | —11,781 at $0.00 | filing |
| 18 Aug 2026filed 20 Aug 2026 | CTKB Cytek Biosciencesoption or derivative · Life-science tools | SEC FORM 4 Code M | —22,100 at $0.00 | filing |
| 18 Aug 2026filed 20 Aug 2026 | CTKB Cytek Biosciencesoption or derivative · Life-science tools | SEC FORM 4 Code M | —29,002 at $0.00 | filing |
| 18 Aug 2026filed 20 Aug 2026 | CTKB Cytek Biosciencesoption or derivative · Life-science tools | SEC FORM 4 Code M | —57,212 at $0.00 | filing |
| 18 Aug 2026filed 20 Aug 2026 | CTKB Cytek BiosciencesLife-science tools | SEC FORM 4 Code F | $25K5,382 at $4.67 | filing |
| 18 Aug 2026filed 20 Aug 2026 | CTKB Cytek BiosciencesLife-science tools | SEC FORM 4 Code M | —29,002 | filing |
| 18 Aug 2026filed 20 Aug 2026 | CTKB Cytek BiosciencesLife-science tools | SEC FORM 4 Code F | $33K7,062 at $4.67 | filing |
| 18 Aug 2026filed 20 Aug 2026 | CTKB Cytek BiosciencesLife-science tools | SEC FORM 4 Code M | —57,212 | filing |
| 18 Aug 2026filed 20 Aug 2026 | CTKB Cytek BiosciencesLife-science tools | SEC FORM 4 Code F | $98K20,956 at $4.67 | filing |
| 18 Aug 2026filed 20 Aug 2026 | CTKB Cytek Biosciencesoption or derivative · Life-science tools | SEC FORM 4 Code M | —11,781 at $0.00 | filing |
| 18 Aug 2026filed 20 Aug 2026 | CTKB Cytek BiosciencesLife-science tools | SEC FORM 4 Code M | —11,781 | filing |
| 18 Aug 2026filed 20 Aug 2026 | CTKB Cytek BiosciencesLife-science tools | SEC FORM 4 Code F | $13K2,869 at $4.67 | filing |
| 18 Aug 2026filed 20 Aug 2026 | CTKB Cytek BiosciencesLife-science tools | SEC FORM 4 Code M | —22,100 | filing |
| 18 Aug 2026filed 20 Aug 2026 | CTKB Cytek BiosciencesLife-science tools | SEC FORM 4 Code F | $25K5,382 at $4.67 | filing |
News
No headline names them, or the companies they trade most, lately.